drugset / Trial / NCT01487837

Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.

NCT01487837

Phase 4 Completed 57 enrolled University Children's Hospital, Zurich
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare two different thromboelastometry (ROTEM) trigger levels for administration of human fibrinogen concentrate (Haemocomplettan P) in the treatment of perioperative dilutional coagulopathy during major pediatric surgery. The study hypothesis is that administration of fibrinogen concentrate triggered by a ROTEM FibTEM MCF \< 13 mm might reduce the total amount of transfused red cell concentrate during 24 hours after start of surgery as compared to a trigger level of ROTEM FibTEM MCF \< 8 mm.

Timeline

Start
2012-01
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic 30 mg/kg